CLINICAL AND EPIDEMIOLOGICAL PROFILE OF ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH REFERENCE TO PREHOSPITAL AND IN-HOSPITAL DELAYS: A PROSPECTIVE OBSERVATIONAL STUDY
Main Article Content
Keywords
ST-elevation myocardial infarction, Prehospital delay, In-hospital delay, Reperfusion therapy, Primary PCI, Thrombolysis, Risk factors, Mortality
Abstract
Background: ST-elevation myocardial infarction (STEMI) continues to be a major cause of morbidity and mortality worldwide, with earlier age of onset and higher prevalence in South Asian populations. Despite the availability of reperfusion therapies, prehospital and in-hospital delays remain significant contributors to adverse outcomes.
Objectives: This study aimed to analyze the clinical and epidemiological profile of STEMI patients presenting to a tertiary care hospital, evaluate the magnitude of treatment delays, and assess associated complications and outcomes.
Methods: A prospective observational study was conducted on 161 consecutive patients with confirmed STEMI admitted to the Emergency Department of a tertiary care center over a one-year period. Data regarding demographics, risk factors, symptom onset, prehospital and in-hospital delays, reperfusion therapy, complications, and outcomes were collected through structured questionnaires and medical records. Statistical analysis was performed using R software, with categorical variables expressed as percentages and continuous variables as mean ± SD.
Results: The mean age of patients was 56.8 ± 11.7 years, with a male predominance (72.7%). Hypertension (58.4%), diabetes mellitus (44.1%), and smoking (39.7%) were the most prevalent risk factors. The mean prehospital delay was 178 minutes, with 62% of patients arriving beyond the recommended 120-minute window. Thrombolysis was administered in 68% of cases, while 21% underwent primary PCI. Complications included arrhythmias (21.1%), cardiogenic shock (11.2%), and pulmonary edema (7.5%). The in-hospital mortality rate was 9.9%.
Conclusion: STEMI patients in this cohort presented late, with significant delays contributing to high complication rates and mortality. Strengthening community awareness and improving emergency medical services are crucial to reducing treatment delays and improving outcomes.
References
2. Thrane P, Olesen KKW, Thim T, Gyldenkerne C, Kristensen SD, Maeng M. Trends in mortality and ischemic outcomes in STEMI patients following implementation of a primary PCI strategy, 2003–2017. Eur Heart J. 2017;43(Suppl 2): ehac544.1319
3. Alrawashdeh A, Nehme Z, Williams B, Smith K, Brennan A, Dinh DT, et al. Impact of emergency medical service delays on time to reperfusion and mortality in STEMI. Open Heart. 2017;8(1): e001654
4. Żurowska-Wolak M, Piekos P, Jkaa J, Mikos M. Effects of prehospital system delays on treatment efficacy in STEMI patients. Scand J Trauma Resusc Emerg Med. 2015; 27:39
5. Scharlach D, Schmitz T, Raake P, Linseisen J, Meisinger C. Causes of death and trends in mortality from 2000 to 2017 in patients with acute myocardial infarction. Ann Med. 2017;56(1):2424449
6. García-García C, Oliveras T, El Ouaddi N, Rueda F, Serra J, Labata C, et al. Short- and long-term mortality trends in STEMI cardiogenic shock: Ruti-STEMI-Shock Registry (1989–2017). J Clin Med. 2017;9(8):2398
7. Zeymer U, Ludman P, Danchin N, Kala P, Laroche C, Sadeghi M, et al. Reperfusion therapies and in-hospital outcomes for STEMI in Europe: ACVC-EAPCI EORP STEMI Registry. Eur Heart J. 2017;42(44):4536–4549
8. ESC Press Office. Prevalence of STEMI across Europe: incidence declined from 111.5/100,000 in 2007 to 72.7/100,000 in 2016. Eur Soc Cardiol Report. 2016
9. Effect of Shorter Door-to-Balloon Times Over 20 Years on Outcomes of Anterior STEMI. Am J Cardiol. 2017;120(6):1045–1053
10. Lancet STEMI Reperfusion Trialists. Comparative efficacy and safety of reperfusion therapy with fibrinolytics versus PCI in STEMI. Lancet. 2017;390(10096):31441–1

